Menu
Home Contact
Brain Tune Exomind
May 12, 2025 7 min read KarmatmsAdmin

How Successful is TMS Treatment? Success Rates, Statistics & Real-World Outcomes

Dive deeper into the clinical outcomes, understanding response vs. remission, and what to expect from your TMS journey.

How Successful is TMS Treatment?

When considering a new medical treatment, especially for mental health conditions like Major Depressive Disorder (MDD) or Anxiety, the most pressing question is often: "Does it work?" For patients who have not found relief with traditional medications, TMS involves a significant commitment of time and hope. Fortunately, the data is compelling.

Understanding "Success": Response vs. Remission

In clinical psychiatry, success is typically measured in two ways: Response and Remission.

Response

A "clinical response" is generally defined as a 50% or greater reduction in symptom severity. This means you feel significantly better, your daily functioning improves, and the burden of depression lifts substantially.

Remission

Remission means the virtual disappearance of symptoms. The patient is no longer considered clinically depressed and returns to their pre-depression baseline of functioning.

The Statistics: What the Data Shows

TMS has been extensively studied in both clinical trials and real-world practice. For patients dealing with Treatment-Resistant Depression (TRD)—those who have failed multiple medications—TMS outcomes are remarkably positive.

50-60%

Response Rate

Of patients achieve at least 50% improvement

~33%

Remission Rate

Of patients achieve complete symptom relief

To put this in perspective: The famous STAR*D study showed that for patients who have already failed 2 or more antidepressants, the chance of achieving remission with a 3rd medication is less than 15%. TMS more than doubles this likelihood.

Factors Influencing Success

While TMS is highly effective, individual results can vary. Several factors can influence outcome success:

  • Treatment Adherence: Completing the full course of 36 sessions is critical for "rewiring" the brain's neural pathways.
  • Concurrent Therapy: Combining TMS with psychotherapy often yields better results than either treatment alone.
  • Lifestyle Factors: Sleep, diet, and substance use (alcohol/drugs) can impact the brain's ability to heal (neuroplasticity).

Long-Term Results & Durability

TMS is not just a quick fix; it creates structural changes in the brain. Research indicates that the benefits are durable.

12-Month Durability

Follow-up studies show that approximately 60-70% of patients who respond to TMS maintain their improvement 12 months after treatment.

TMS Effectiveness for Depression

Depression is the most extensively studied condition for TMS therapy, with the strongest evidence base.

Clinical Trial Results

Industry-Sponsored Trials

  • Response rate: 58%
  • Remission rate: 37%
  • Average symptom reduction: 47%
  • Treatment completion rate: 92%

NIMH Independent Study

  • Response rate: 58%
  • Remission rate: 37%
  • Benefits maintained at 6-month follow-up
  • Validated real-world effectiveness

Large-Scale Meta-Analysis

Pooled analysis of 29 randomized controlled trials (1,371 patients):

  • Overall response rate: 52%
  • Remission rate: 31%
  • Significantly superior to sham treatment (placebo)
  • Consistent results across different study populations

Comparison to Other Treatments

Treatment Response Rate Remission Rate
TMS Therapy 50-60% 30-40%
Second Antidepressant Trial 20-30% 10-15%
Electroconvulsive Therapy (ECT) 70-90% 50-60%
Psychotherapy Alone 40-50% 25-35%

*Response and remission rates for treatment-resistant depression populations

TMS Success with Other Conditions

While depression has the most extensive research, TMS shows promising results for several other mental health conditions:

Anxiety Disorders

Anxiety responds well to TMS therapy, particularly when it co-occurs with depression.

  • Generalized Anxiety: 50-70% response rate
  • Panic Disorder: 40-60% symptom reduction
  • Anxious Depression: FDA-approved indication with 55% response rate
  • Significant reduction in worry, tension, and physical anxiety symptoms

Obsessive-Compulsive Disorder (OCD)

OCD is the second condition to receive FDA approval for TMS treatment.

  • Response Rate: 35-45% show significant improvement
  • FDA Approval: Granted in 2018 based on strong clinical evidence
  • Reduces both obsessions and compulsive behaviors
  • Effective for treatment-resistant cases

Post-Traumatic Stress Disorder (PTSD)

Emerging evidence shows TMS can help with PTSD symptoms, especially in veterans.

  • Response Rate: 40-55% in preliminary studies
  • Reduces intrusive thoughts, hypervigilance, and emotional numbness
  • Particularly effective when combined with trauma therapy
  • VA hospitals expanding TMS access for PTSD

Conclusion

The success rates of TMS therapy offer a beacon of hope for those who have exhausted other options. With high response rates, a favorable safety profile, and durable results, it stands as one of the most effective treatments in modern psychiatry.

If you are ready to see if you can be part of the success story, schedule a consultation with Dr. Sunder today.

Dr. Keerthy Sunder

Medical Director

Dr. Keerthy Sunder

Board-Certified Psychiatrist | KarmaTMS

Dr. Keerthy Sunder oversees all TMS treatments at KarmaTMS. He is dedicated to providing legitimate, evidence-based care to the Palm Springs community.

Frequently Asked Questions

Yes, TMS therapy is FDA-approved. It was deemed safe and effective for the treatment of Major Depressive Disorder (MDD) in 2008. Since then, the FDA has also cleared TMS for treating Obsessive-Compulsive Disorder (OCD), smoking cessation, and anxiety symptoms associated with depression.
Absolutely. TMS therapy is backed by decades of clinical research and numerous peer-reviewed studies. Clinical trials have consistently demonstrated its effectiveness, with success rates often showing that 50-60% of patients experience significant improvement, and approximately one-third achieve full remission from their symptoms.
Yes. TMS is recognized as a standard-of-care treatment by leading medical organizations worldwide, including the American Psychiatric Association (APA) and the National Institute of Mental Health (NIMH). It is widely practiced in top-tier medical centers such as Mayo Clinic, Johns Hopkins, and Cleveland Clinic.
Most major insurance providers, including Medicare, Anthem Blue Cross, Blue Shield, UnitedHealthcare, Cigna, and Aetna, cover TMS therapy for the treatment of Major Depressive Disorder. Coverage typically requires that you have tried medication and psychotherapy without sufficient relief.
Unlike antidepressants, which are systemic and circulate chemicals throughout the entire body, TMS is a targeted treatment that works directly on the specific area of the brain involved in mood regulation. This means it avoids common medication side effects like weight gain, sexual dysfunction, and drowsiness. It is also non-invasive, unlike Electroconvulsive Therapy (ECT), and requires no anesthesia or recovery time.
TMS is considered very safe and well-tolerated. It does not involve surgery or anesthesia. The most common side effect is mild scalp discomfort or a headache during or after treatment, which typically diminishes as your body adjusts. Serious side effects are extremely rare.

Ready to Try a Proven Treatment?

Schedule a free consultation to discuss if FDA-approved TMS therapy is right for you.

Related Articles

Is TMS Therapy Permanent?

Is TMS Therapy Permanent?

Discover the long-term effectiveness of TMS and what to expect.

Read More
Is TMS Therapy Legitimate?

Is TMS Therapy Legitimate?

Learn about the science, FDA approval, and legitimacy of TMS.

Read More
Why TMS Requires Multiple Sessions

Why TMS Requires Multiple Sessions

Understand the protocol and why neuroplasticity takes time.

Read More